US Broker Ratings

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 65.98% Potential Upside for a Biotech Innovator

Vera Therapeutics, Inc. (NASDAQ: VERA) is capturing the attention of individual investors and analysts alike, driven by its promising pipeline and a striking potential upside of..

National HealthCare Corporation (NHC) Stock Analysis: A Deep Dive into a Resilient Healthcare Player

National HealthCare Corporation (NYSE: NHC), a key player in the healthcare sector, has carved a niche for itself in the medical care facilities industry with a..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a Potential Upside of 354.53% with Innovative Cancer Therapies

Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment and a staggering..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 24% Upside Potential in the Booming Biotech Sector

Investors with a keen eye on the biotechnology sector may find Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) an intriguing prospect, given its strong growth potential and innovative..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 10% Potential Upside in Healthcare Plans

Alignment Healthcare, Inc. (ALHC) is gaining attention in the healthcare sector, particularly for its focus on transforming senior healthcare through innovative Medicare Advantage plans. Headquartered in..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 71.99% Potential Upside

Surgery Partners, Inc. (NASDAQ: SGRY) is making waves in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.91 billion,..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a 44.9% Potential Upside Amidst Healthcare Innovations

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, stands at the forefront of innovation in the field of targeted therapeutics and immunotherapies. Specializing..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Assessing a Potential 97.3% Upside for Biotechnology Investors

Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, is drawing significant attention from investors due to a compelling potential upside of 97.3%...

Neogen Corporation (NEOG) Stock Analysis: Healthcare Diagnostics Firm with 13.82% Upside Potential

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, is drawing investor attention with its impressive potential upside of..

Addus HomeCare Corporation (ADUS) Investor Outlook: A 33.88% Potential Upside Beckons

Investors eyeing opportunities in the healthcare sector might find Addus HomeCare Corporation (ADUS) an appealing prospect. With a focus on providing comprehensive personal care, hospice, and..

Teladoc Health, Inc. (TDOC) Investor Outlook: Is the 66% Upside Within Reach?

Teladoc Health, Inc. (NYSE: TDOC), a leader in virtual healthcare services, has captured investor attention with its significant potential upside of 66.33%. Despite current challenges, the..

Twist Bioscience Corporation (TWST) Stock Analysis: Unraveling the Growth Potential in Synthetic DNA

Twist Bioscience Corporation (NASDAQ: TWST) is making waves in the healthcare sector, particularly within the diagnostics and research industry. With a current market capitalization of $2.87..

Omnicell, Inc. (OMCL) Stock Analysis: Investor Optimism Soars with 15.87% Potential Upside

Omnicell, Inc. (NASDAQ: OMCL) has been catching the attention of investors as it steadily positions itself as a key player in the healthcare sector, particularly within..

Catalyst Pharmaceuticals, Inc. (CPRX): Analyst Ratings Highlight 38% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is making waves in the biotechnology sector with a compelling growth narrative and an impressive analyst outlook. The company, based in..

Harmony Biosciences Holdings (HRMY) Stock Analysis: A Promising 22.77% Upside with Strong Buy Ratings

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its substantial potential upside of 22.77%, according to the latest analyst ratings...

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A Potential 8.12% Upside Beckons Investors

Guardian Pharmacy Services, Inc. (GRDN) is catching the eye of investors with its robust performance and promising potential upside. As a key player in the healthcare..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech with 100% Potential Upside and Strong Buy Ratings

Immunocore Holdings plc (NASDAQ: IMCR), a UK-based biotechnology company, is creating ripples in the healthcare sector with its innovative approach to immunotherapy. As a commercial-stage company,..

Evotec SE (EVO) Stock Analysis: Exploring a 63.93% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector might find Evotec SE (EVO) an intriguing prospect. With a market capitalization of $1.21 billion, this German-based company is..

AtriCure, Inc. (ATRC) Stock Analysis: A Compelling 43% Upside Potential for Investors

For investors keen on the healthcare sector, AtriCure, Inc. (NASDAQ: ATRC) presents an intriguing opportunity. This Ohio-based company, with a market cap of $1.83 billion, specializes..

Brookdale Senior Living Inc. (BKD) Stock Analysis: A Compelling 21.41% Potential Upside for Investors

Brookdale Senior Living Inc. (NYSE: BKD) stands as a formidable player within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Brentwood, Tennessee,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds